Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis

Acute Exacerbation of Chronic Bronchitis Clinical Trial

Official title: Double-blind, A Multicenter, Randomized, Placebo-controlled, Parallel, Phase 2 Study to Comparative Evaluate the Efficacy of N02RS1 600mg/Day, 12,00mg/Day in Korean Patients With Acute and Chronic Bronchitis

Status Completed

Clinical Trial Summary

The Purpose of A Multicenter, Randomized, Double-blind, Placebo-controlled to Evaluate the Efficacy, Safety and Pharmacokinetics of N02RS1 600mg and 1,200mg per day in Patients With acute and acute exacerbation of chronic bronchitis for 7 days.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Acute Exacerbation of Chronic Bronchitis
• Bronchitis
• Bronchitis, Chronic

• NCT number: NCT01979926
• Study type: Interventional
• Source: PharmaKing
• Status: Completed
• Phase: Phase 2
• Start date: November 2013
• Completion date: March 2014